Open-market purchases of Inhibrx Biosciences, Inc. (INBX) stock by its own executives, directors and 10% owners — every Form 4 buy of $250K or more that SPX Lens's daily insider scan has recorded, newest first.
| Scan | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Mark P. LappeCEO & Director | $849K | Added | |||
| Weighted avg price ~$84.56 across 6 purchase transactions on Oct 14. Purchases split between Lappe Family Trust (5,040 shares, ~$426K) and Lappe Descendants' Trust (4,900 shares, ~$422K) — dual-vehicle cluster buy. Post-buy direct holdings 745,588 shares. Now $85.26 (+0.8% since buy). | ||||||
| Sep 29, 2026 | Mark LappeCEO | $999K | Added | |||
| Two tranches on 9/25: 5,500 shares at $99.16 and 4,500 shares at $100.76 (avg ~$99.88); now $101.71 (+1.8% since buy). Founder-CEO has purchased ~$3.6M in INBX this month. Serial buyer throughout 2026. | ||||||
| Sep 24, 2026 | Jon Faiz KayyemDirector | $500K | Added | |||
| Clean round-lot purchase of 5,000 shares at exactly $100/share via the Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Trust held ~429K shares prior. Current $100.33 (+0.3% vs buy). | ||||||
| Sep 9, 2026 | Mark P. LappeChief Executive Officer | $2.65M | Added | |||
| Six tranches Sept 8 at $99.29–$112.28; avg $105.81. Now $114.34 (+8.1% since buy). Part of three-insider cluster: CEO + 2 directors bought same day for combined ~$3.5M. | ||||||
| Sep 9, 2026 | Jon Faiz KayyemDirector | $568K | Added | |||
| 5,000 shares Sept 8 at $113.30–$113.55; avg $113.52. Now $114.34 (+0.7% since buy). Via Kayyem family trust. Part of three-insider cluster at INBX. | ||||||
| Sep 9, 2026 | Douglas G. ForsythDirector | $287K | Added | |||
| 2,500 shares Sept 8 at $114.36–$114.69; avg $114.65. Now $114.34 (−0.3% since buy). Via Forsyth Family Trust. Part of three-insider cluster at INBX. | ||||||
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.